drugset / Trial / NCT00978549

Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer

NCT00978549 ↗

RandomizedOpen-labelTreatment

Summary

RATIONALE: Analgesics, antiemetics, steroids, and radiation therapy are effective in helping to control symptoms caused by cancer. It is not yet known whether these treatments are more effective when given with or without docetaxel in treating patients with relapsed esophageal cancer or stomach cancer. PURPOSE: This randomized phase II trial is studying symptom control given together with docetaxel to see how well it works compared with symptom control given without docetaxel in treating patients with relapsed esophageal cancer or stomach cancer.

Timeline

Start
2008-04
Primary completion
2010-04
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule — Intravenous